Search Results

Displaying Results 1101-1125 of 2130 "'SEED'"

Mar 05, 2026, 09:30 ET WK KELLOGG PUTS FIBER AT THE FOREFRONT THIS NATIONAL CEREAL DAY USING ICONIC BRANDS TO CREATE SIMPLE 'FIBER HACKS'

RD)3-4g fiber per 2 piece serving1 cup slightly crushed Kellogg's Raisin Bran®¼ cup peanut, almond or sunflower seed butter1 tablespoon honey1 tablespoon ground flaxseed1 tablespoon hemp seedsMix well. Scoop into 2-tablespoon

More news about: WK Kellogg Co


Mar 05, 2026, 09:00 ET Stamus Networks Appoints Mark Firmin as CEO and Patrick Deane as CFO

technology businesses – four to strategic acquirers and two to private equity firms, including the acquisition of ACOMPay by American Express.A seed-round investor in Stamus Networks through VisionTech Partners and a board member since 2025, Firmin steps into the CEO role with a deep understanding

More news about: Stamus Networks


Mar 05, 2026, 09:00 ET Stamus Networks Appoints Mark Firmin as CEO and Patrick Deane as CFO

technology businesses – four to strategic acquirers and two to private equity firms, including the acquisition of ACOMPay by American Express.A seed-round investor in Stamus Networks through VisionTech Partners and a board member since 2025, Firmin steps into the CEO role with a deep understanding

More news about: Stamus Networks


Mar 05, 2026, 08:30 ET Lio Raises $30M Series A to Bring Agentic AI to Enterprise Procurement

Horowitz (aka a16z) is a venture capital firm that backs bold entrepreneurs building the future through technology. We are stage agnostic: We invest in seed to venture to growth-stage technology companies, across bio + healthcare, consumer and enterprise apps, crypto, fintech, infrastructure, and companies

More news about: Lio Technologies GmbH


Mar 05, 2026, 08:30 ET Lio Raises $30M Series A to Bring Agentic AI to Enterprise Procurement

Horowitz (aka a16z) is a venture capital firm that backs bold entrepreneurs building the future through technology. We are stage agnostic: We invest in seed to venture to growth-stage technology companies, across bio + healthcare, consumer and enterprise apps, crypto, fintech, infrastructure,

More news about: Lio Technologies GmbH


Mar 05, 2026, 08:30 ET Decoy Therapeutics Announces 1-for-12 Reverse Stock Split

cancers. Decoy has attracted financing from institutional investors as well as significant non-dilutive capital from the Massachusetts Life Sciences Seed Fund, the Google AI startup program and the NVIDIA Inception program among other sources. The company has also received QuickFire Challenge award funding

More news about: Decoy Therapeutics, Inc


Mar 05, 2026, 08:30 ET Münchner Startup Lio Technologies sichert sich $30 Mio. Series A zur Implementierung von Agentic AI in die Unternehmensbeschaffung

Venture-Capital-Gesellschaft, die ambitionierte Gründer unterstützt, die mit Technologie die Zukunft gestalten. Das Unternehmen ist phasenagnostisch und investiert von Seed- über Venture- bis hin zu Wachstumsphasen in Technologieunternehmen – unter anderem in den Bereichen KI, Bio + Healthcare, Consumer, Krypto, Enterprise,

More news about: Lio Technologies GmbH


Mar 05, 2026, 08:00 ET AgriPass Raises $7.5M Seed Round to Scale Human-Inspired AI for Adaptive and Selective Weed Control Across the U.S. and Europe

 TEL AVIV, Israel, March 5, 2026 /PRNewswire/ -- AgriPass has completed a $7.5M seed funding round to accelerate the commercial scale-up of RHIC, its human-inspired robotic weed control platform, to expand across the United States and

More news about: AgriPass


Mar 05, 2026, 08:00 ET ZyG Launches an Agentic Operating System for eCom Scale

The end-to-end platform validates demand, executes growth, and finances scale for direct-to-consumer brands; ZyG raises $58M seed roundTel Aviv, ISRAEL, March 5, 2026 /PRNewswire/ -- ZyG today announced

More news about: ZyG


Mar 05, 2026, 08:00 ET Corteva Announces Dates for First Quarter 2026 Earnings Release and Webcast

challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. With some of the most recognized brands in agriculture and a technology pipeline well positioned

More news about: Corteva Agriscience


Mar 05, 2026, 08:00 ET Galvanize Raises $370 Million for Strategy Focused on Profitably Decarbonizing Commercial Real Estate

Galvanize is a global asset manager investing at the intersection of energy innovation, resilience, and intelligence. The firm deploys capital across seed, venture, growth, public equities, credit, and real estate, combining investment expertise with deep in-house capabilities in technology, policy, and

More news about: Galvanize


Mar 05, 2026, 07:00 ET NexCure, Inc. Launches with $19 Million Series A Financing to enable CAR-T and other advanced treatment delivery in community outpatient settings

investing in public and private healthcare, life sciences, and planetary health companies. RA Capital creates and funds innovative companies, from private seed rounds to public follow-on financings, allowing management teams to drive value creation from inception through commercialization and beyond. RA Capital's

More news about: NexCure Inc.


Mar 05, 2026, 07:00 ET Evogene Reports Fourth Quarter and Full Year 2025 Financial Results

activities on the Brazilian market. As a result of these developments, Casterra recorded an impairment of approximately $2.2 million related to its seed inventory. This impairment is presented within Cost of Sales in the consolidated financial statements in a separate line item.In February 2026,

More news about: Evogene


Mar 05, 2026, 06:10 ET Inadev Appoints Manish Agarwal as Chief Executive Officer to Lead Company Into Next Era of Innovation and Growth

advisor to government and commercial clients worldwide. Manish is currently the Managing Partner of Attain NextGen Ventures, which provides angel, seed, and growth capital along with strategic mentorship to emerging technology startups. Previously, Manish was a founding member and President of

More news about: Inadev


Mar 04, 2026, 11:17 ET Odditt Launches Bracket Party, a Free March Madness Bracket Tool For Casual Fans

advanced content engines, and user-first design, Odditt builds products that make sports more informative, accessible, and enjoyable.Currently in a seed fundraising round, Odditt is focused on commercializing its fan engagement technologies for B2B partners and scaling owned consumer properties like

More news about: Odditt


Mar 04, 2026, 10:00 ET Predactiv Launches Secure PII Onboarding & Identity Integration with LiveRamp

capabilities. Once PII has been translated into acceptable identifiers, clients can build modeled audiences based on first-party customer data and expand their seed datasets into scalable, high-propensity segments for activation or even build new privacy-compliant data products.Unlocking New Revenue StreamsFor

More news about: Predactiv


Mar 04, 2026, 09:30 ET M.D. Sass Brings High Conviction Value Strategy to ETF Market

new information may invalidate prior  beliefs."SASS will trade on the New York Stock Exchange and will launch with more than $70 million in  seed capital from existing clients and company principals. Marking M.D. Sass' entry into the  ETF marketplace, this launch extends the firm's long-standing

More news about: M.D. Sass


Mar 04, 2026, 09:00 ET NextWork Raises $4.45M Seed Round to Accelerate AI Skill Verification for the Workforce

NextWork, a platform helping people learn practical AI skills by building real projects and publishing proof-of-work portfolios, today announced a $4.45M Seed round led by Shakti VC with participation from Cake Ventures. Repeat investors GD1 VC, Blackbird Ventures, Icehouse Ventures, Phase One Ventures and

More news about: NextWork


Mar 03, 2026, 15:22 ET IntelliGRC Raises $3.5M Seed Round to Scale Provider-Centric Cyber Compliance

(MSPs) and managed security service providers (MSSPs) focused on high-caliber and rigorous cyber frameworks, announced the closing of its $3.5 million Seed round on January 31, 2026. The funding accelerates product innovation, expands AI-driven capabilities, and scales go-to-market initiatives focused on

More news about: IntelliGRC


Mar 03, 2026, 11:30 ET Worldscape.ai Raises Seed Funding to Accelerate AI-Native Geospatial Intelligence for Defense and Enterprise

developer of AI-powered geospatial intelligence software for defense, government, and enterprise applications, today announced the completion of its seed funding round. The round was led by 

More news about: Worldscape.ai


Mar 03, 2026, 10:55 ET EGI Battery Announces Successful Close of $10 Million Seed Round

/PRNewswire/ -- EGI Battery Inc., a U.S.-based advanced battery technology and manufacturing company, today announced the successful close of a $10 million seed financing round led by TSV Capital and supported by several prominent U.S. family offices. The new capital will accelerate the company's manufacturing

More news about: EGI Battery Inc.


Mar 03, 2026, 10:00 ET Predactiv Introduces New Lookalike Modeling Feature In The Predactiv Data Platform For Advertising Success and New Product Development

increase the overall value of their data assets.Through a simplified, guided workflow, users can:Onboard single or multiple seed data securely into The Predactiv Data PlatformAutomatically create modeled audiences using predictive intelligence and enrichment signalsExpand

More news about: Predactiv


Mar 03, 2026, 09:00 ET REPROCELL、臨床用iPSCsのGMPマスターセルバンク製造を開始

ドナーの調達と適格性は、FDA、EMA、PMDAの要件を満たし、治療目的での使用に関する全面的な同意を得ています。FDA/EMA/PMDAの要件に基づき、StemRNA™ Clinical iPSC Seed Clonesを生成するためのフットプリントフリーの独自のRNAリプログラミングを採用しています。アクティブなFDA DMFに支えられた米国由来の StemRNA Clinical Seed ClonesStemRNA Clinical Seed Clones向けの全ゲノムシーケンス(WGS) を用いた遺伝的完全性と発がんリスク評価高いオンターゲット効率とオフターゲット活性の低減、予測される免疫原性の低減のために設計された臨床用遺伝子編集サービス「StemEdit」 FDAに準拠、またはEMAおよびPMDAの製造認可のもとで製造するGMP

More news about: REPROCELL USA


Mar 03, 2026, 09:00 ET REPROCELL Launches GMP Master Cell Bank Manufacturing for Clinical iPSCs

generate StemRNA™ Clinical iPSC Seed Clones under FDA/EMA/PMDA requirements.US-generated StemRNA Clinical Seed Clones supported by an active FDA DMFGenetic integrity and oncogenic risk assessment using whole-genome sequencing (WGS) for StemRNA Clinical Seed ClonesStemEdit clinical

More news about: REPROCELL USA


Mar 03, 2026, 09:00 ET REPROCELL Launches GMP Master Cell Bank Manufacturing for Clinical iPSCs

generate StemRNA™ Clinical iPSC Seed Clones under FDA/EMA/PMDA requirements.US-generated StemRNA Clinical Seed Clones supported by an active FDA DMFGenetic integrity and oncogenic risk assessment using whole-genome sequencing (WGS) for StemRNA Clinical Seed ClonesStemEdit clinical

More news about: REPROCELL USA


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.